Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Thursday, June 20, 2019  Spokane, Washington  Est. May 19, 1883
Partly Cloudy Day 63° Partly Cloudy
News >  Pacific NW

Washington, California sue over pelvic mesh implants

UPDATED: Tue., May 24, 2016, 2:21 p.m.

This Monday, July 15, 2013, file photo shows Johnson & Johnson baby products for sale at a pharmacy in Miami. Washington state and California sued Johnson & Johnson on Tuesday, May 24, 2016, saying that the company misrepresented the risks of vaginal mesh implants it sold. (Lynne Sladky / Associated Press)
This Monday, July 15, 2013, file photo shows Johnson & Johnson baby products for sale at a pharmacy in Miami. Washington state and California sued Johnson & Johnson on Tuesday, May 24, 2016, saying that the company misrepresented the risks of vaginal mesh implants it sold. (Lynne Sladky / Associated Press)
By Gene Johnson Associated Press

SEATTLE – Washington state and California sued Johnson & Johnson on Tuesday, saying that for years the company misrepresented the risks of vaginal mesh implants it sold to repair pelvic collapse.

In the latest legal actions over the problem-prone devices, Attorneys General Bob Ferguson of Washington and Kamala Harris of California accused the New Jersey-based health care giant of neglecting to tell patients and doctors about the risks and occurrences of dire, sometimes irreversible complications. Those include urinary dysfunction, loss of sexual function, constipation and severe pain.

“For many victims, their health and their quality of life were forever changed as a result of this deception,” Ferguson told a news conference. “Sitting upright, lying on their side, walking all became incredibly painful. … These women were robbed of their ability to live and work in the way they once did.”

Patients have already filed tens of thousands of lawsuits against mesh manufacturers, including New Jersey-based Johnson & Johnson, Massachusetts-based Boston Scientific and Ireland-based Endo International. In 2014, Endo said it would pay $830 million to settle more than 20,000 personal injury lawsuits. Johnson & Johnson faces more than 35,000 lawsuits, Harris said.

The plastic mesh is used to treat pelvic organ prolapse, a condition that involves organs such as the bladder, bowel and uterus shifting, often after childbirth, a hysterectomy or menopause. In response to thousands of injuries from the mesh, the U.S. Food and Drug Administration early this year relabeled the products high risk instead of moderate and announced new federal scrutiny for them. The agency had already concluded that women getting vaginal mesh have more complications than women who undergo traditional surgery with stitches.

In an emailed statement, Johnson & Johnson subsidiary Ethicon Inc., which marketed the mesh, called the lawsuits unjustified.

“The evidence will show that Ethicon acted appropriately and responsibly in the marketing of our pelvic mesh products,” the company said. “The use of implantable mesh is often the preferred option to treat certain female pelvic conditions, including pelvic organ prolapse and stress urinary incontinence, and is backed by years of clinical research.

“Ethicon is concerned that the Attorneys General’s decision to file its lawsuit will keep women from obtaining treatment for the often-debilitating symptoms of stress urinary incontinence.”

California and Washington led a group of 46 states and the District of Columbia in investigating the company’s practices. California’s lawsuit alleges false advertising and deceptive marketing. In a news release, Harris noted that Johnson & Johnson sold nearly 790,000 of the devices nationwide from 2008 to 2014, including more than 42,000 in California.

Washington’s lawsuit alleges tens of thousands of violations of the state’s consumer protection law and seeks penalties that could reach well into the millions of dollars. Ferguson said Johnson & Johnson sold 12,000 of the devices in Washington, but it never told patients the mesh can cause chronic inflammation as their body rejects the foreign material; that the mesh harbors infections that can live indefinitely in its small weave; or that the mesh frequently protrudes into an organ or through the vaginal wall.

Subscribe to the Morning Review newsletter

Get the day’s top headlines delivered to your inbox every morning by subscribing to our newsletter.

You have been successfully subscribed!
There was a problem subscribing you to the newsletter. Double check your email and try again, or email webteam@spokesman.com